Table 4.
Attitude towards HPV Vaccination (n = 313)
| Agree | Undecided | Disagree | |
|---|---|---|---|
| I am susceptible to acquire HPV infection | 160 (51.1) | 50 (15.0) | 103 (32.9) |
| HPV vaccine is safe and effective in preventing cervical cancer | 245 (78.3) | 16 (5.1) | 52 (16.6) |
| Being vaccinated for HPV can reduce risk of having HPV infection | 233 (74.4) | 26 (8.3) | 54 (17.3) |
| HPV vaccine will lead to complicated sexual activities in future | 141 (45.0) | 50 (16.0) | 122 (39.0) |
| HPV vaccine will promote risky sexual behavior | 123 (39.3) | 37 (11.8) | 153 (48.9) |
| HPV vaccine will encourage early sexual activity | 121 (38.7) | 44 (14.1) | 148 (47.3) |
| Are you afraid of side effects of HPV vaccine like redness, pain, etc | 183 (58.5) | 43 (13.7) | 87 (27.8) |
| Do you fear infertility due to HPV vaccination | 145 (46.3) | 31 (9.9) | 137 (43.8) |
| Those who are multiple sexual partner would benefit from the HPV vaccine | 202 (64.5) | 36 (11.5) | 75 (24.0) |
| I feel embarrassed to get HPV vaccine | 96 (30.7) | 46 (14.7) | 171 (54.6) |
| I think taking vaccine will keep me safe and healthy | 256 (81.8) | 27 (8.6) | 30 (9.6) |
| The cost of vaccine discourages me from taking HPV vaccine | 124 (39.6) | 56 (17.9) | 133 (42.5) |
| HPV vaccine should be prescribed routinely to young population in India | 222 (70.9) | 34 (10.9) | 57 (18.2) |
| I feel it is better to be vaccinated before becoming sexually active | 207 (66.1) | 43 (13.7) | 63 (20.2) |
| I feel only sexually active women should take vaccine | 127 (40.6) | 42 (13.4) | 144 (46.0) |
| Are you worried about short term side effects of HPV vaccine | 159 (50.8) | 48 (15.3) | 106 (33.9) |
| HPV vaccine may have long term side effect on me | 102 (32.6) | 67 (21.4) | 144 (46.0) |
| HPV vaccine should be included in National immunization schedule | 229 (73.2) | 32 (10.2) | 52 (16.6) |
| Vaccine must be carried out only in severe disease cases | 149 (47.6) | 46 (14.7) | 118 (37.7) |
| If I am vaccinated, I can protect other people by preventing spread of infection | 232 (74.1) | 31 (9.9) | 50 (16.0) |